scholarly journals Health Economic Analysis of Catheter Ablation for Ventricular Tachycardia: Breaking Even With Medical Therapy?

2019 ◽  
Vol 35 (2) ◽  
pp. 147-149
Author(s):  
Pablo B. Nery ◽  
Mouhannad M. Sadek ◽  
Girish M. Nair
Keyword(s):  
Health Economic ◽  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Economic Analysis ◽  
Medical Therapy ◽  
Health Economic Analysis

scholarly journals PCVI4 AN ECONOMIC ANALYSIS OF CATHETER ABLATION FORTHE TREATMENT OF VENTRICULAR TACHYCARDIA

2004 ◽  
Vol 7 (6) ◽  
pp. 689
Author(s):  
C Reyes ◽  
J Hernandez ◽  
S Duff ◽  
T Knight ◽  
H Calkins
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Economic Analysis

PROTECT - trial: a multicentre prospective pragmatic RCT and health economic analysis of the effect of tailored repositioning to prevent pressure ulcers - study protocol

2016 ◽  
Vol 73 (2) ◽  
pp. 495-503 ◽  
Author(s):  
Dorien De Meyer ◽  
Nele Van Damme ◽  
Karen Van den Bussche ◽  
Ann Van Hecke ◽  
Sofie Verhaeghe ◽  
...  
Keyword(s):  
Health Economic ◽  
Economic Analysis ◽  
Study Protocol ◽  
Pressure Ulcers ◽  
Health Economic Analysis

scholarly journals Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in article

2020 ◽  
Vol 21 (3) ◽  
pp. 230-231
Author(s):  
Karen Thomas ◽  
Akshay Patel ◽  
M Zia Sadique ◽  
Richard D Grieve ◽  
Alexina J Mason ◽  
...  
Keyword(s):  
Health Economic ◽  
Economic Analysis ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Randomised Clinical Trial ◽  
Open Label ◽  
Health Economic Analysis ◽  
Permissive Hypotension ◽  
Critical Care Units ◽  
Parallel Group

The 65 trial is a pragmatic, multicentre, parallel-group, open-label, randomised clinical trial of permissive hypotension (targeting a mean arterial pressure target of 60–65 mmHg during vasopressor therapy) versus usual care in critically ill patients aged 65 years or over with vasodilatory hypotension. The trial will recruit 2600 patients from 65 United Kingdom adult general critical care units. The primary outcome is all-cause mortality at 90 days. An economic evaluation is embedded. This paper describes the proposed statistical and health economic analysis for the 65 trial.

Sign in / Sign up

Export Citation Format

Share Document